AlphaNet, Inc. was founded in 1995 with a mission to provide disease management to persons with Alpha-1 antitrypsin deficiency (Alpha-1). Currently, AlphaNet follows over 6,000 Alpha-1 patients and employs regional AlphaNet Coordinators, all individuals with Alpha-1.
Our disease management program is comprehensive and structured to meet the specific needs of persons diagnosed with Alpha-1 antitrypsin deficiency. The program is built on clinical and organizational principles that have emerged from the relatively new field of disease management.
The Alpha-1 Disease Management and Prevention Program or ADMAP was developed by AlphaNet to support not only the individual Alpha but also their families and health care providers. We define ADMAP as an integrated system of education, interventions, measurements and refinements of health care delivery designed to optimize clinical and economic outcomes for persons with Alpha-1. The goal is to prevent disease, improve the quality of life and efficiently manage health resources for individuals with Alpha-1. Click HERE to find and contact your local coordinator to join the AlphaNet program.